Michelle Chen

CBO at Insilico Medicine

Speaker

Michelle Chen is the Chief Business Officer of Insilico Medicine, a global leader in generative AI-driven drug discovery & development. She is responsible for the company’s business and corporate development, portfolio strategies, marketing, and US operations.

As a biotech executive, Michelle brings in 20+ years of experience in the biopharma and life sciences industries, having worked at multi-national companies such as Roche, Merck, BioMarin, Agilent, as well as small biotech companies. She has a strong track record of success in company building, BD&L, M&A, R&D, marketing, and product commercialization.

Michelle has a Ph.D. in Biochemistry from the University of Washington, did her postdoctoral work at UCSF, and received Bioinformatics training at Stanford.